MedPath

安徽双鹤药业有限责任公司

Ownership
-
Established
2000-09-13
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

103

NMPA:103

Drug Approvals

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20247329
Approval Date
Dec 30, 2024
NMPA

Sodium Bicarbonate Ringer's Injection

Product Name
碳酸氢钠林格注射液
Approval Number
国药准字H20249422
Approval Date
Nov 22, 2024
NMPA

Linezolid and Glucose Injection

Product Name
利奈唑胺葡萄糖注射液
Approval Number
国药准字H20243447
Approval Date
Apr 7, 2024
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20237041
Approval Date
Apr 19, 2023
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20184043
Approval Date
Feb 1, 2023
NMPA

Matrine and Glucose Injection

Product Name
林希
Approval Number
国药准字H20030743
Approval Date
Oct 31, 2022
NMPA

Potassium Dehydroandroandrographolide Succinate and Sodium Chloride Injection

Product Name
合尔
Approval Number
国药准字H20050814
Approval Date
Oct 31, 2022
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20227123
Approval Date
Sep 23, 2022
NMPA

Azithromycin and Glucose Injection

Product Name
林比
Approval Number
国药准字H20020680
Approval Date
Sep 6, 2021
NMPA

Propylgaclate and Sodium Chloride Injection

Product Name
合比
Approval Number
国药准字H20050868
Approval Date
Sep 6, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.